Skip to main content

Table 4 Proportions (numbers) of males and females using cardiovascular medication (CVM) in 2008 by their cardiovascular risk scores in 1997-1999.

From: Does present use of cardiovascular medication reflect elevated cardiovascular risk scores estimated ten years ago? A population based longitudinal observational study

Risk score

Males (n = 9 283)

Females (n = 10 969)

 

Use of CVM (%)

Framingham 60y ≥ 20%

37.1 (n = 1 533)

56.2 (n = 356)

Framingham 60y < 20%

17.1 (n = 878)

20.2 (n = 2 092)

SCORE 60y ≥ 5%

34.6 (n = 1 712)

76.1 (n = 108)

SCORE 60y < 5%

16.1 (n = 699)

21.6 (n = 2 340)

NORRISK ≥1%

40.0 (n = 1 071)

72.6 (n = 53)

NORRISK < 1%

20.3 (n = 1 340)

21.9 (n = 2 395)

BP > 150/95 mm Hg

82.7 (n = 7 677)

87.9 (n = 9 642)

Cholesterol > 8 mmol/l

58.1 (n = 5 393)

64.4 (n = 7 064)